vs

Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and GRID DYNAMICS HOLDINGS, INC. (GDYN). Click either name above to swap in a different company.

GRID DYNAMICS HOLDINGS, INC. is the larger business by last-quarter revenue ($104.1M vs $85.1M, roughly 1.2× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -1.4%, a 24.2% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 3.7%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 12.0%).

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.

FDMT vs GDYN — Head-to-Head

Bigger by revenue
GDYN
GDYN
1.2× larger
GDYN
$104.1M
$85.1M
FDMT
Growing faster (revenue YoY)
FDMT
FDMT
+8508896.3% gap
FDMT
8508900.0%
3.7%
GDYN
Higher net margin
FDMT
FDMT
24.2% more per $
FDMT
22.8%
-1.4%
GDYN
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
12.0%
GDYN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FDMT
FDMT
GDYN
GDYN
Revenue
$85.1M
$104.1M
Net Profit
$19.4M
$-1.5M
Gross Margin
34.8%
Operating Margin
17.3%
61.7%
Net Margin
22.8%
-1.4%
Revenue YoY
8508900.0%
3.7%
Net Profit YoY
139.1%
-150.6%
EPS (diluted)
$0.43
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FDMT
FDMT
GDYN
GDYN
Q1 26
$104.1M
Q4 25
$85.1M
$106.2M
Q3 25
$90.0K
$104.2M
Q2 25
$15.0K
$101.1M
Q1 25
$14.0K
$100.4M
Q4 24
$1.0K
$100.3M
Q3 24
$3.0K
$87.4M
Q2 24
$5.0K
$83.0M
Net Profit
FDMT
FDMT
GDYN
GDYN
Q1 26
$-1.5M
Q4 25
$19.4M
$306.0K
Q3 25
$-56.9M
$1.2M
Q2 25
$-54.7M
$5.3M
Q1 25
$-48.0M
$2.9M
Q4 24
$4.5M
Q3 24
$-43.8M
$4.3M
Q2 24
$-35.0M
$-817.0K
Gross Margin
FDMT
FDMT
GDYN
GDYN
Q1 26
34.8%
Q4 25
34.0%
Q3 25
33.3%
Q2 25
34.1%
Q1 25
36.8%
Q4 24
36.9%
Q3 24
37.4%
Q2 24
35.6%
Operating Margin
FDMT
FDMT
GDYN
GDYN
Q1 26
61.7%
Q4 25
17.3%
0.5%
Q3 25
-67983.3%
-0.2%
Q2 25
-396373.3%
-0.1%
Q1 25
-383007.1%
-2.0%
Q4 24
1.3%
Q3 24
-1704400.0%
2.4%
Q2 24
-849120.0%
0.0%
Net Margin
FDMT
FDMT
GDYN
GDYN
Q1 26
-1.4%
Q4 25
22.8%
0.3%
Q3 25
-63195.6%
1.1%
Q2 25
-364386.7%
5.2%
Q1 25
-342657.1%
2.9%
Q4 24
4.5%
Q3 24
-1461433.3%
4.9%
Q2 24
-699060.0%
-1.0%
EPS (diluted)
FDMT
FDMT
GDYN
GDYN
Q1 26
$-0.02
Q4 25
$0.43
$0.01
Q3 25
$-1.01
$0.01
Q2 25
$-0.98
$0.06
Q1 25
$-0.86
$0.03
Q4 24
$0.06
Q3 24
$-0.79
$0.05
Q2 24
$-0.63
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FDMT
FDMT
GDYN
GDYN
Cash + ST InvestmentsLiquidity on hand
$402.7M
$327.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$505.7M
$530.1M
Total Assets
$566.7M
$605.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FDMT
FDMT
GDYN
GDYN
Q1 26
$327.5M
Q4 25
$402.7M
$342.1M
Q3 25
$305.1M
$338.6M
Q2 25
$293.2M
$336.8M
Q1 25
$321.4M
$325.5M
Q4 24
$424.9M
$334.7M
Q3 24
$501.9M
$231.3M
Q2 24
$541.9M
$256.0M
Stockholders' Equity
FDMT
FDMT
GDYN
GDYN
Q1 26
$530.1M
Q4 25
$505.7M
$542.1M
Q3 25
$369.0M
$537.7M
Q2 25
$420.9M
$532.2M
Q1 25
$469.7M
$517.4M
Q4 24
$510.6M
$517.8M
Q3 24
$552.9M
$400.2M
Q2 24
$588.3M
$388.4M
Total Assets
FDMT
FDMT
GDYN
GDYN
Q1 26
$605.0M
Q4 25
$566.7M
$612.9M
Q3 25
$424.0M
$613.2M
Q2 25
$473.6M
$608.9M
Q1 25
$515.7M
$590.9M
Q4 24
$560.4M
$592.2M
Q3 24
$604.0M
$477.3M
Q2 24
$620.1M
$443.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FDMT
FDMT
GDYN
GDYN
Operating Cash FlowLast quarter
$28.6M
Free Cash FlowOCF − Capex
$28.5M
FCF MarginFCF / Revenue
33.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
1.47×
TTM Free Cash FlowTrailing 4 quarters
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FDMT
FDMT
GDYN
GDYN
Q1 26
Q4 25
$28.6M
$9.9M
Q3 25
$-46.5M
$7.0M
Q2 25
$-43.4M
$14.4M
Q1 25
$-47.8M
$9.4M
Q4 24
$-134.6M
$7.1M
Q3 24
$-29.4M
$9.2M
Q2 24
$-30.2M
$10.7M
Free Cash Flow
FDMT
FDMT
GDYN
GDYN
Q1 26
Q4 25
$28.5M
$6.1M
Q3 25
$-46.6M
$2.9M
Q2 25
$-43.4M
$10.2M
Q1 25
$-48.4M
$6.0M
Q4 24
$-138.4M
$4.4M
Q3 24
$-31.2M
$5.9M
Q2 24
$-30.6M
$8.0M
FCF Margin
FDMT
FDMT
GDYN
GDYN
Q1 26
Q4 25
33.5%
5.7%
Q3 25
-51765.6%
2.8%
Q2 25
-289620.0%
10.1%
Q1 25
-345635.7%
6.0%
Q4 24
-13837100.0%
4.4%
Q3 24
-1038966.7%
6.8%
Q2 24
-611840.0%
9.7%
Capex Intensity
FDMT
FDMT
GDYN
GDYN
Q1 26
Q4 25
0.1%
3.6%
Q3 25
101.1%
3.9%
Q2 25
440.0%
4.1%
Q1 25
4507.1%
3.3%
Q4 24
378600.0%
2.6%
Q3 24
59266.7%
3.7%
Q2 24
6980.0%
3.2%
Cash Conversion
FDMT
FDMT
GDYN
GDYN
Q1 26
Q4 25
1.47×
32.34×
Q3 25
5.92×
Q2 25
2.73×
Q1 25
3.21×
Q4 24
1.56×
Q3 24
2.15×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons